Canadian Cardiovascular Society commentary on implantable cardioverter defibrillators in Canada: Waiting times and access to care issues

Canadian Journal of Cardiology

Volumn 21, Issue SUPPL. A, 2005, Pages

  Simpson, C S ^a,h   O'Neill, B J ^b   Sholdice, M M ^c   Dorian, P ^c   Kerr, C R ^d   Ross, D B ^e   Ross, H ^f   Brophy, J M ^g  

^a QUEEN S UNIVERSITY   (Canada)

^b DALHOUSIE UNIVERSITY   (Canada)

^c ST MICHAEL'S HOSPITAL   (Canada)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^e UNIVERSITY OF ALBERTA   (Canada)

^f UNIVERSITY HEALTH NETWORK   (Canada)

^g MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^h KINGSTON GENERAL HOSPITAL   (Canada)

Author keywords

Health policy; Implantable cardioverter defibrillator; Sudden death; Waiting times

Indexed keywords

CANADA; DEFIBRILLATOR; HEALTH CARE POLICY; MEDICAL RESEARCH; MEDICAL SOCIETY; PREVALENCE; REVIEW;

CANADA; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; HEALTH SERVICES ACCESSIBILITY; HUMANS; TIME FACTORS; WAITING LISTS;

EID: 33744797152     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (16)

1. Connolly SJ, Hallstrom AP, Cappato R, et al. Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs implantable defibrillator study. Cardiac arrest study Hamburg. Canadian implantable defibrillator study. Eur Heart J 2000;21:2071-8.
2. Lee DS, Green LD, Liu PP, et al. Effectiveness of implantable defibrillators for preventing arrhythmic events and death: A meta-analysis. J Am Coll Cardiol 2003;41:1573-82.
3. Bardy GH. SCD-HeFT: The sudden cardiac death in heart failure trial. 〈http://sicr.org/scdheft_results_acc_lbcc.pdf〈 (Version current at January 1, 2005).
4. Tang AS, Ross H, Simpson CS, et al. Canadian Cardiovascular Society/Canadian Heart Rhythm Society position paper on implantable cardioverter defibrillator use in Canada. Can J Cardiol 2005;21(Suppl A):11A-18A.
5. McCullough PA, Philbin EF, Spertus JA, et al. Confirmation of a heart failure epidemic: Findings from the Resource Utilization Among Congestive Heart Failure (REACH) study. J Am Coll Cardiol 2002;39:60-9.
6. Nudell BM. CRM: Confirmation of a 1.1 million Patient Pool for ICDs. Bernstein Research Call. New York: Sanford C Bernstein and Co, 2004:1-9.
7. IMS Health, Canadian Compuscript 2004. Canadian Drug Store and Hospital Purchasing Audit 2004.
8. The Technology Assessment Unit of the McGill University Health Centre. Use of the Implantable Cardiac Defibrillator (ICD) at the McGill University Health Centre (MUHC). 〈http://upload.mcgill.ca/ tau/icd.pdf〉 (Version current at January 4, 2005).
9. Blue Cross and Blue Shield Assoc, Technology Assessment Program, 2004;109:1-25.
10. Implantable defibrillators cost-effective for many heart failure patients. 〈http://www.dukehealth.org/HealthPortals/heart/news/8273〉 (Version current at March 1, 2005).
11. Dorian P, Mangat I, Korley V. Do Canadian cardiologists agree with arrhythmia guidelines? Heart Rhythm 2004;1S:S33.
12. Wilson S, Kadwell S, Kane C, Crysler J. Variations in utilization of implantable cardioverter defibrillators across Canada. Can J Cardiol 2004;20:147D.
13. Gillis AM. Referring patients for consideration of device treatment of sudden cardiac death and heart failure: Incorporating evidence-based therapies within the Canadian health care system. Can J Cardiol 2005;21(Suppl A):25A-30A.
14. Cardiac Care Network of Ontario. 〈http://www.ccn.on.ca/access. html〉 (Version current at January 3, 2005).
15. Moss AJ, Zareba W, Hall WJ, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002;346:877-83.
16. Canadian Nurses Association. The taming of the queue. 〈http://cna-aiic.ca/CNA/documents/pdf/publications/Taming_Queue_e. pdf〉 (Version curent at January 3, 2005).